San Francisco, CA, United States of America

Lori Jean Van Orden

This inventor holds 22 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in JAK Inhibitors. Top assignees: Theravance Biopharma R&d IP, LLC, Theravance, Inc., Neumora Therapeutics, Inc.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lori Jean Van Orden. Retrieved from https://idiyas.com/inventor/lori-jean-van-orden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 2)

% Patents Active = 72.7

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 6.0

ph-index = 7

Forward Citations = 150(Granted Patents)

Company Filing History:

19 out of 262

Theravance Biopharma R&d IP, LLC

Neumora Therapeutics, Inc.

patents

Years Active: 2013-2024

Loading Chart...

Areas of Expertise:

JAK Inhibitors

Hepatitis C Virus

Serotonin Reuptake Inhibitors

4-Membered Heterocyclic Amide

Fused Imidazo-Piperidine

Respiratory Disease

Kinase Inhibitor Compounds

Piperazine-Piperidine Compounds

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171758 - Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto (2024-12-24),

2. 11878977 - JAK inhibitors containing a 4-membered heterocyclic amide (2024-01-23),

3. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease (2023-08-08),

4. 11667637 - Fused imidazo-piperidine JAK inhibitors (2023-06-06),

5. 11453668 - JAK inhibitors containing a 4-membered heterocyclic amide (2022-09-27),

6. 11299492 - JAK kinase inhibitor compounds for treatment of respiratory disease (2022-04-12),

7. 11254669 - Fused imidazo-piperidine JAK inhibitors (2022-02-22),

8. 10954237 - JAK inhibitors containing a 4-membered heterocyclic amide (2021-03-23),

9. 10550118 - JAK inhibitors containing a 4-membered heterocyclic amide (2020-02-04),

10. 10526330 - JAK kinase inhibitor compounds for treatment of respiratory disease (2020-01-07),

11. 10519153 - Fused imidazo-piperidine JAK inhibitors (2019-12-31),

12. 10392386 - JAK inhibitors containing a 4-membered heterocyclic amide (2019-08-27),

13. 10208040 - Fused imidazo-piperidine JAK inhibitors (2019-02-19),

14. 10196393 - JAK inhibitors containing a 4-membered heterocyclic amide (2019-02-05),

15. 10100049 - JAK kinase inhibitor compounds for treatment of respiratory disease (2018-10-16),

Title: Lori Jean Van Orden - Innovative Inventor from San Francisco

Introduction: Lori Jean Van Orden is a pioneering inventor based in San Francisco, CA, known for her groundbreaking contributions to various industries.

Latest Patents: Lori Jean Van Orden holds several patents in the fields of technology and healthcare, with her most recent inventions focusing on sustainable energy solutions and medical devices.

Career Highlights: With a career spanning over two decades, Lori Jean Van Orden has established herself as a leading figure in the innovation landscape, consistently pushing the boundaries of what is possible through her inventive spirit.

Collaborations: Throughout her career, Lori Jean Van Orden has collaborated with top research institutions, universities, and companies to bring her ideas to life, showcasing her ability to work effectively in multidisciplinary teams.

Conclusion: Lori Jean Van Orden's passion for innovation and her relentless drive to create a positive impact on society make her a true inspiration in the world of inventors.

Profile summary based on public USPTO records.